Connect your AI

Merck & Co. MRK Total Current Assets

Total Current Assets at other companies

Bristol-Myers SquibbBMY

$28.58B-14.0%

PfizerPFE

$42.82B-6.6%

Johnson & JohnsonJNJ

$59.77B+9.7%

Regeneron PharmaceuticalsREGN

$18.45B+9.4%

CytokineticsCYTK

$839.47M-12.2%

Phibro Animal HealthPAHC

$894.07M+15.2%

Other financials

Income statement

Revenue$16.3B+4.9%

Gross profit$12.1B-0.2%

Net income-$4.2B-183%

EPS (diluted)-$1.72-186%

Balance sheet

Cash & equivalents$5.4B-38.2%

Total debt$49.1B+35.8%

Total equity$45.9B-5.1%

Total assets$128.69B+11.8%

Cash flow

Operating cash flow$3.9B+56.7%

CapEx$991.0M-25.4%

Free cash flow$2.9B+150%

Valuation

Market cap$325.57B+56.9%

Enterprise value$369.27B+56.3%

P/E36.4×+23.8×

P/S5×+1.7×

Profitability

Gross margin73.9%-2.5pp

Net margin13.6%-13.7pp

FCF margin21.5%-5.2pp

Returns & leverage

Return on equity19%-20.3pp

Debt / equity1.1×+0.3×

Current ratio1.3×-0.1×

Where this comes from

Reported directly by Merck & Co. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Merck & Co.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merck & Co.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Merck & Co.'s total current assets?: Merck & Co. (MRK) reported total current assets of $35.02B in Q1 2026.
How has Merck & Co.'s total current assets changed year-over-year?: Merck & Co.'s total current assets decreased by 1.4% year-over-year, from $35.5B to $35.02B.
What is the long-term trend for Merck & Co.'s total current assets?: Over 5 years (2020 to 2025), Merck & Co.'s total current assets has grown at a 9.4% compound annual growth rate (CAGR), from $27.76B to $43.52B.
What does total current assets mean?: The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.